Condition
NAFLD - Nonalcoholic Fatty Liver Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 5 NAFLD - Nonalcoholic Fatty Liver Disease clinical trials that are recruiting, at sites in 4 countries (most in United Kingdom (2), Kuwait (1), China (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest NAFLD - Nonalcoholic Fatty Liver Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Low‑methoxy pectin for inflammation, gut microbiome, and metabolic health in MASLD | — | Nottingham, United Kingdom and 2 other locations | Recruiting | Jul 30, 2025 |
| Low‑methoxy pectin for inflammation, gut microbiome, and metabolic health in MASLD | — | Nottingham, United Kingdom and 2 other locations | Recruiting | Jul 30, 2025 |
| Digital early-warning system to predict acute lung injury after major liver surgery | — | Beijing, Beijing Municipality and 3 other locations | Recruiting | Jul 17, 2025 |
| Kuwait Adult Diabetes Epidemiological Multidisciplinary Program | — | Kuwait City | Recruiting | Nov 3, 2023 |
| Observational cohort for non-alcoholic fatty liver disease and related conditions | — | Roma, Rome/lazio/italy | Recruiting | May 1, 2020 |
All recruiting trials (5)
-
Low‑methoxy pectin for inflammation, gut microbiome, and metabolic health in MASLD
This tests whether taking daily low‑methoxy pectin for six weeks can reduce inflammation and improve gut bacteria and metabolic markers in adults with MASLD.
-
Low‑methoxy pectin for inflammation, gut microbiome, and metabolic health in MASLD
This tests whether taking daily low‑methoxy pectin for six weeks can reduce inflammation and improve gut bacteria and metabolic markers in adults with MASLD.
-
Digital early-warning system to predict acute lung injury after major liver surgery
This study will try a machine-learning based warning tool to predict early acute lung injury in adults having major liver surgery.
-
Kuwait Adult Diabetes Epidemiological Multidisciplinary Program
This study looks at people in Kuwait to see how obesity and genetics affect the risk of developing prediabetes and diabetes, hoping to find better ways to prevent these conditions.
-
Observational cohort for non-alcoholic fatty liver disease and related conditions
This study is trying to learn more about non-alcoholic fatty liver disease and its related conditions by looking at patients with different stages of the disease and comparing them to people with diabetes and obesity who don't have it.
Related topics
Quick answers
How many NAFLD - Nonalcoholic Fatty Liver Disease clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United Kingdom (2 trials), Kuwait (1 trial), China (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.